Power to the Patients

Listen to this episode on:

• Spotify
• Apple
• YouTube
• Amazon

Today’s episode features Victoria DiBiaso from Sanofi. Victoria provides a detailed analysis of patient-informed development and the critical importance of diversity and inclusion in clinical trials. With her unique perspective stemming from her nursing background, she explains the significance of patient-centric trials and the future of healthcare. 

Throughout the episode, Victoria elaborates on effective communication with patient communities, the significance of trust-building, and how understanding social determinants of health can aid in forging strong relationships with patient advisors. The episode further explores the world of drug development, from considering patient-relevant endpoints to health scales and label opportunities.  

Topics Discussed:

• An explanation of patient-informed development 
• The meaning of patient centricity 
• Stumbling blocks to patient centricity 
• Cross-industry collaboration milestones 
• The new voice Victoria wants to bring forward 
• How to talk about clinical trials in language patients want to hear 
• Important factors in implementing patient-centric solutions
• What the future of patient-centric clinical trials looks like 
• What modern patient recruitment means 
• How Victoria would change clinical trials overnight if she had a magic wand 
• How to learn more about what Victoria is doing 

Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation.

Power is a modern clinical trial marketplace. We help patients access research and help trials recruit more patients.